Click HERE to register.

The Best of Breast is an innovatively designed multidisciplinary CME/MOC meeting, developed to translate podium to practice. During this 2-day conference, attendees will be immersed in a familiar tumor board environment, where medical oncologists, surgeons, radiation oncologists, breast radiologists, pathologists, pharmacists, advanced practitioners, nurses, and patients and survivors will discuss and debate the present and evolving state of breast cancer care.

Designed to start at screening and prevention and conclude with survivorship, world experts will present carefully engineered cases and clear and concise practice strategies that follow global and national guidelines, but also consider data where guidelines are silent or controversial.

Overview and Target Audience

The Best of Breast is a new and innovative conference on breast cancer set completely in a multidisciplinary tumor board environment. The world's leading breast cancer experts will discuss cases beginning with high risk characteristics and take us through to survivorship all the while incorporating data from the major oncologic annual meetings. Expert panelists include breast surgeons, plastic surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, geneticists, psychologists, pharmacists, advanced practitioners, and nurses. The conference also offers incredible opportunities for networking and collaboration.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Analyze new strategies in screening and prevention, especially in at-risk populations. 
• Define the optimal patient demographic for the array of genomic assays, including the definitions of prognostic value, predictive value, and negative predictive value. 
• Discuss controversies around medical marijuana and CBD in managing side effects. 
• Discuss new radiation plans and strategies for breast cancer patients in each stage of disease. 
• Manage the issues in family planning in the treatment of breast cancer. 
• Evaluate the validity and utility of NGS testing in breast cancer. 
• Discuss the most beneficial treatment strategies for adjuvant disease. 
• Evaluate new and emerging treatment strategies in Triple Negative Breast Cancer. 
• Distinguish the role of the AJCC staging guidelines in practice. Discuss the roles of the interprofessional team in the continuum of care for the patient. 
• Discuss various issues in HER2 testing. 
• Discuss surgical strategies for breast cancer patients in each stage of disease.

Accreditation and Credit Statements - Physician

The Medical Educator Consortium designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.